NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,975,395 | -41.1% | 431,913 | +51.5% | 0.13% | -42.7% |
| Q2 2023 | $11,834,804 | +136.5% | 285,176 | +242.8% | 0.23% | +131.7% |
| Q1 2023 | $5,003,708 | +2294.1% | 83,201 | +2660.5% | 0.10% | +1022.2% |
| Q2 2022 | $209,000 | -77.0% | 3,014 | -72.5% | 0.01% | -77.5% |
| Q1 2022 | $907,000 | -76.8% | 10,951 | -79.0% | 0.04% | -82.1% |
| Q4 2021 | $3,915,000 | +149.8% | 52,147 | +124.1% | 0.22% | -64.3% |
| Q1 2020 | $1,567,000 | +295.7% | 23,266 | +394.9% | 0.62% | +443.5% |
| Q4 2019 | $396,000 | – | 4,701 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |